These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35411048)

  • 21. Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker.
    Johansson P; Laguna T; Ossowski J; Pancaldi V; Brauser M; Dührsen U; Keuneke L; Queiros A; Richter J; Martín-Subero JI; Siebert R; Schlegelberger B; Küppers R; Dürig J; Murga Penas EM; Carillo-de Santa Pau E; Bergmann AK
    Clin Epigenetics; 2022 Nov; 14(1):148. PubMed ID: 36376973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune-mediated bone marrow failure syndromes of progenitor and stem cells: molecular analysis of cytotoxic T cell clones.
    Maciejewski JP; O'Keefe C; Gondek L; Tiu R
    Folia Histochem Cytobiol; 2007; 45(1):5-14. PubMed ID: 17378239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
    Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Large Granular Lymphocytic Leukemia and JAK/STAT Signaling Pathway--Review].
    Qiu ZY; Fan Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):254-60. PubMed ID: 26913432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D decreases STAT phosphorylation and inflammatory cytokine output in T-LGL leukemia.
    Olson KC; Kulling PM; Olson TL; Tan SF; Rainbow RJ; Feith DJ; Loughran TP
    Cancer Biol Ther; 2017 May; 18(5):290-303. PubMed ID: 27715403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TCR-Vbeta flow cytometric analysis of peripheral blood for assessing clonality and disease burden in patients with T cell large granular lymphocyte leukaemia.
    Feng B; Jorgensen JL; Hu Y; Medeiros LJ; Wang SA
    J Clin Pathol; 2010 Feb; 63(2):141-6. PubMed ID: 20154036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantation.
    Link CS; Eugster A; Heidenreich F; Rücker-Braun E; Schmiedgen M; Oelschlägel U; Kühn D; Dietz S; Fuchs Y; Dahl A; Domingues AM; Klesse C; Schmitz M; Ehninger G; Bornhäuser M; Schetelig J; Bonifacio E
    Clin Exp Immunol; 2016 Jun; 184(3):389-402. PubMed ID: 26800118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia.
    Rajala HL; Olson T; Clemente MJ; Lagström S; Ellonen P; Lundan T; Hamm DE; Zaman SA; Lopez Marti JM; Andersson EI; Jerez A; Porkka K; Maciejewski JP; Loughran TP; Mustjoki S
    Haematologica; 2015 Jan; 100(1):91-9. PubMed ID: 25281507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Successful treatment of large granular lymphocytic leukemia accompanied by refractory anemia with alemtuzumab].
    Iijima K; Hirao M; Hino T; Kamoda Y; Iizuka H; Kida M; Hangaishi A; Usuki K
    Rinsho Ketsueki; 2017; 58(12):2392-2396. PubMed ID: 29332872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts.
    Woolaver RA; Wang X; Krinsky AL; Waschke BC; Chen SMY; Popolizio V; Nicklawsky AG; Gao D; Chen Z; Jimeno A; Wang XJ; Wang JH
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33414263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcomes in T-cell large granular lymphocytic leukaemia: prognostic factors and treatment response.
    Braunstein Z; Mishra A; Staub A; Freud AG; Porcu P; Brammer JE
    Br J Haematol; 2021 Feb; 192(3):484-493. PubMed ID: 32519348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. STAT3 mutation and its clinical and histopathologic correlation in T-cell large granular lymphocytic leukemia.
    Shi M; He R; Feldman AL; Viswanatha DS; Jevremovic D; Chen D; Morice WG
    Hum Pathol; 2018 Mar; 73():74-81. PubMed ID: 29288042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell large granular lymphocytic (LGL) leukemia consists of CD4
    Kuwahara N; Kodaka T; Zushi Y; Sasaki M; Goka T; Maruoka H; Aoyama Y; Tsunemine H; Yamane T; Kobayashi J; Kawakami T; Ishida F; Itoh T; Takahashi T
    J Clin Exp Hematop; 2019; 59(4):202-206. PubMed ID: 31866622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL).
    Sanikommu SR; Clemente MJ; Chomczynski P; Afable MG; Jerez A; Thota S; Patel B; Hirsch C; Nazha A; Desamito J; Lichtin A; Pohlman B; Sekeres MA; Radivoyevitch T; Maciejewski JP
    Leuk Lymphoma; 2018 Feb; 59(2):416-422. PubMed ID: 28633612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoglobulin and T-cell receptor gene rearrangement and expression in human lymphoid leukemia cells at different stages of maturation.
    Davey MP; Bongiovanni KF; Kaulfersch W; Quertermous T; Seidman JG; Hershfield MS; Kurtzberg J; Haynes BF; Davis MM; Waldmann TA
    Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8759-63. PubMed ID: 3464980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transformed aggressive γδ-variant T-cell large granular lymphocytic leukemia with acquired copy neutral loss of heterozygosity at 17q11.2q25.3 and additional aberrations.
    Zhang L; Ramchandren R; Papenhausen P; Loughran TP; Sokol L
    Eur J Haematol; 2014 Sep; 93(3):260-4. PubMed ID: 24635703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D pathway activation selectively deactivates signal transducer and activator of transcription (STAT) proteins and inflammatory cytokine production in natural killer leukemic large granular lymphocytes.
    Olson KC; Kulling Larkin PM; Signorelli R; Hamele CE; Olson TL; Conaway MR; Feith DJ; Loughran TP
    Cytokine; 2018 Nov; 111():551-562. PubMed ID: 30455079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune Repertoire Sequencing Using Molecular Identifiers Enables Accurate Clonality Discovery and Clone Size Quantification.
    Ma KY; He C; Wendel BS; Williams CM; Xiao J; Yang H; Jiang N
    Front Immunol; 2018; 9():33. PubMed ID: 29467754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular analysis of TCR clonotypes in LGL: a clonal model for polyclonal responses.
    O'Keefe CL; Plasilova M; Wlodarski M; Risitano AM; Rodriguez AR; Howe E; Young NS; Hsi E; Maciejewski JP
    J Immunol; 2004 Feb; 172(3):1960-9. PubMed ID: 14734782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High Incidence of Clonal CD8+ T-cell Proliferation in Non-malignant Conditions May Reduce the Significance of T-cell Clonality Assay for Differential Diagnosis in Oncohematology.
    Sidorova YV; Sychevskaya KA; Chernova NG; Julhakyan HL; Smirnova SJ; Ryzhikova NV; Gorodetskiy VR; Naumova EV; Sudarikov AB
    Clin Lymphoma Myeloma Leuk; 2020 Apr; 20(4):203-208. PubMed ID: 32046930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.